The diagnosis and treatment of breast cancer has evolved significantly over the last 20 years. Breast-conserving therapy is replacing the Halstedian concept of "en bloc" resection. Difficulties in detection, pre- and postoperative planning and follow up continue to challenge the clinician. Women at high risk present a significant clinical dilemma. MRI technology in many of these areas is providing more information about detection, tumor size, extent, and response to treatment. The careful and thoughtful inclusion of MRI in clinical trials may help continue the advancement of breast cancer care. J. Magn. Reson. Imaging 2001;13:837-841.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/jmri.1119 | DOI Listing |
Publication Analysis
Top Keywords
clinical trials
8
breast cancer
8
mri role
4
role clinical
4
trials diagnosis
4
diagnosis treatment
4
treatment breast
4
cancer evolved
4
evolved years
4
years breast-conserving
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!